Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Côte d'Ivoire

Côte d'Ivoire: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology was 0.6% in 2024. ▼ Falling

Latest (2024)
0.6%
Change on year
unchanged
Rank
2nd
of 6 groups
All-time high
1.6%
in 2015
All-time low
0.6%
in 2023
Years of data
10
2015–2024

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Côte d'Ivoire, 2015–2024

00.511.52015201920242015: 1.62016: 1.42017: 12018: 12019: 12020: 0.82021: 0.72022: 0.72023: 0.62024: 0.6

Source: United Nations Statistics Division, SDG Global Database.

Analysis

In 2024, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Côte d'Ivoire stood at 0.6%. That is the lowest value across all 10 years on record.

The figure is down 62.5% over ten years.

Over the whole period, prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Côte d'Ivoire peaked at 1.6% in 2015 and was at its lowest, 0.6%, in 2023.

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Côte d'Ivoire, year by year

Annual values for Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%) in Côte d'Ivoire, 2015 to 2024.
Year Value Change
2015 1.6%
2016 1.4% -12.5%
2017 1.0% -28.6%
2018 1.0% +0.0%
2019 1.0% +0.0%
2020 0.8% -20.0%
2021 0.7% -12.5%
2022 0.7% +0.0%
2023 0.6% -14.3%
2024 0.6% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2010s 1.2% 1.0% 1.6% 5
2020s 0.7% 0.6% 0.8% 5

Countries ranked near Côte d'Ivoire

  1. 1 Cabo Verde 0.7% compare
  2. 1 Central African Republic 5.3% compare
  3. 2 Democratic Republic of the Congo 1.4% compare
  4. 2 Somalia 4.0% compare
  5. 3 Gabon 3.2% compare
  6. 3 Niger 3.2% compare
  7. 3 Timor-Leste 1.0% compare
  8. 4 Viet Nam 0.9% compare
  9. 5 Angola 3.1% compare

See the full ranking of 236 places →

More development goals data for Côte d'Ivoire

All data for Côte d'Ivoire →

Frequently asked questions

What is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Côte d'Ivoire?
Prevalence of hepatitis b surface antigen (hbsag), 2026 methodology in Côte d'Ivoire was 0.6% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Côte d'Ivoire?
The highest recorded value was 1.6% in 2015.
What is the lowest prevalence of hepatitis b surface antigen (hbsag), 2026 methodology recorded in Côte d'Ivoire?
The lowest recorded value was 0.6% in 2023.
How does Côte d'Ivoire rank for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Côte d'Ivoire ranks 2nd out of 6 groups with data for 2024.
Is prevalence of hepatitis b surface antigen (hbsag), 2026 methodology rising or falling in Côte d'Ivoire?
Over the last ten years it is down 62.5%. The long-run trend across the full record is falling.
Where does this Côte d'Ivoire data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 10 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Côte d'Ivoire. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 03 September 2026, from https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/cote-d-ivoire-3/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/stat/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/cote-d-ivoire-3/">Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology in Côte d'Ivoire</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
236 places, 2,360 data points, 2015–2024
Last refreshed